Validation of cyclooxygenase-2 as a direct anti-inflammatory target of 4-O-methylhonokiol in zymosan-induced animal models

[1]  C. Müller,et al.  The Natural Product Magnolol as a Lead Structure for the Development of Potent Cannabinoid Receptor Agonists , 2013, PloS one.

[2]  X. Y. Zhang,et al.  Vascular and upper gastrointestinal effects of non-steroidal anti-inflammatory drugs: meta-analyses of individual participant data from randomised trials , 2013, BDJ.

[3]  Dae-Young Lee,et al.  Neolignans from the Fruits of Magnolia obovata and Their Inhibition Effect on NO Production in LPS-Induced RAW 264.7 Cells , 2013, Planta Medica.

[4]  J. Hong,et al.  Dendritic cell activation by polysaccharide isolated from Angelica dahurica. , 2013, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[5]  J. Hong,et al.  Sophoricoside isolated from Sophora japonica ameliorates contact dermatitis by inhibiting NF-κB signaling in B cells. , 2013, International immunopharmacology.

[6]  B. Jespersen,et al.  The effects of calcineurin inhibitors on prostanoid synthesis: a randomized cross‐over study in healthy humans , 2013, Transplant international : official journal of the European Society for Organ Transplantation.

[7]  Yunhe Fu,et al.  Magnolol inhibits lipopolysaccharide-induced inflammatory response by interfering with TLR4 mediated NF-κB and MAPKs signaling pathways. , 2013, Journal of ethnopharmacology.

[8]  J. Hong,et al.  Inhibition of TAK1 by kamebakaurin in dendritic cells. , 2013, International immunopharmacology.

[9]  J. Hong,et al.  Effusanin C inhibits inflammatory responses via blocking NF-κB and MAPK signaling in monocytes. , 2013, International immunopharmacology.

[10]  Jinzhong Zhang,et al.  Anti-inflammatory Effects of Mapracorat, a Novel Selective Glucocorticoid Receptor Agonist, Is Partially Mediated by MAP Kinase Phosphatase-1 (MKP-1) , 2012, The Journal of Biological Chemistry.

[11]  D. Yoon,et al.  4-O-methylhonokiol inhibits colon tumor growth via p21-mediated suppression of NF-κB activity. , 2012, The Journal of nutritional biochemistry.

[12]  S. Ryu,et al.  Inhibition of LPS binding to MD-2 co-receptor for suppressing TLR4-mediated expression of inflammatory cytokine by 1-dehydro-10-gingerdione from dietary ginger. , 2012, Biochemical and biophysical research communications.

[13]  S. Nam,et al.  4-O-methylhonokiol prevents memory impairment in the Tg2576 transgenic mice model of Alzheimer's disease via regulation of β-secretase activity. , 2012, Journal of Alzheimer's disease : JAD.

[14]  S. Nam,et al.  Inhibitory effect of 4-O-methylhonokiol on lipopolysaccharide-induced neuroinflammation, amyloidogenesis and memory impairment via inhibition of nuclear factor-kappaB in vitro and in vivo models , 2012, Journal of Neuroinflammation.

[15]  K. Altmann,et al.  Mechanisms of osteoclastogenesis inhibition by a novel class of biphenyl-type cannabinoid CB(2) receptor inverse agonists. , 2011, Chemistry & biology.

[16]  S. Nam,et al.  Anxiolytic-like effects of 4-O-methylhonokiol isolated from Magnolia officinalis through enhancement of GABAergic transmission and chloride influx. , 2011, Journal of medicinal food.

[17]  G. Ecker,et al.  Modulation of GABAA-receptors by honokiol and derivatives: subtype selectivity and structure-activity relationship. , 2011, Journal of medicinal chemistry.

[18]  H. Lee,et al.  4-O-methylhonokiol attenuated β-amyloid-induced memory impairment through reduction of oxidative damages via inactivation of p38 MAP kinase. , 2011, The Journal of nutritional biochemistry.

[19]  Y. Yun,et al.  4-O-methylhonokiol attenuated memory impairment through modulation of oxidative damage of enzymes involving amyloid-β generation and accumulation in a mouse model of Alzheimer's disease. , 2011, Journal of Alzheimer's disease : JAD.

[20]  D. Y. Hwang,et al.  4-O-Methylhonokiol attenuates memory impairment in presenilin 2 mutant mice through reduction of oxidative damage and inactivation of astrocytes and the ERK pathway. , 2011, Free radical biology & medicine.

[21]  Stephen P. H. Alexander,et al.  International Union of Basic and Clinical Pharmacology. LXXIX. Cannabinoid Receptors and Their Ligands: Beyond CB1 and CB2 , 2010, Pharmacological Reviews.

[22]  J. Hong,et al.  Induction of dendritic cell maturation by β-glucan isolated from Sparassis crispa. , 2010, International immunopharmacology.

[23]  C. Lunn.  Updating the chemistry and biology of cannabinoid CB2 receptor-specific inverse agonists. , 2010, Current Topics in Medicinal Chemistry.

[24]  K. Hua,et al.  Anti-inflammatory bioactivities of honokiol through inhibition of protein kinase C, mitogen-activated protein kinase, and the NF-kappaB pathway to reduce LPS-induced TNFalpha and NO expression. , 2010, Journal of agricultural and food chemistry.

[25]  R. Bauer,et al.  Design and synthesis of ten biphenyl-neolignan derivatives and their in vitro inhibitory potency against cyclooxygenase-1/2 activity and 5-lipoxygenase-mediated LTB4-formation. , 2009, Bioorganic & medicinal chemistry.

[26]  R. Vink,et al.  Recent patents in CNS drug discovery: the management of inflammation in the central nervous system. , 2009, Recent patents on CNS drug discovery.

[27]  S. Nam,et al.  Protective effect of the ethanol extract of Magnolia officinalis and 4-O-methylhonokiol on scopolamine-induced memory impairment and the inhibition of acetylcholinesterase activity , 2009, Journal of Natural Medicines.

[28]  J. D. de Fijter,et al.  Everolimus and sirolimus antagonize tacrolimus based calcineurin inhibition via competition for FK-binding protein 12. , 2009, Biochemical pharmacology.

[29]  W. Schühly,et al.  Neolignans from North American Magnolia Species with Cyclooxygenase 2 Inhibitory Activity , 2009, Inflammopharmacology.

[30]  T. Hirota,et al.  Covalent Binding of Rofecoxib, but Not Other Cyclooxygenase-2 Inhibitors, to Allysine Aldehyde in Elastin of Human Aorta , 2007, Drug Metabolism and Disposition.

[31]  M. Glass,et al.  The cannabinoid CB2 receptor as a target for inflammation-dependent neurodegeneration. , 2007, Current neuropharmacology.

[32]  Y. Yun,et al.  Inhibitory effect of obovatol on nitric oxide production and activation of NF-kappaB/MAP kinases in lipopolysaccharide-treated RAW 264.7cells. , 2007, European journal of pharmacology.

[33]  Jong-Ho Lee,et al.  Prevention of arthritic inflammation using an oriental herbal combination BDX-1 isolated fromAchyranthes bidentata andAtractylodes japonica , 2005, Archives of pharmacal research.

[34]  Robert Riddell,et al.  Cardiovascular events associated with rofecoxib in a colorectal adenoma chemoprevention trial. , 2005, The New England journal of medicine.

[35]  D. Ganea,et al.  Prostaglandin E2 inhibits TNF production in murine bone marrow-derived dendritic cells. , 2003, Cellular immunology.

[36]  K. Madi,et al.  Immunomodulatory and anti-inflammatory effects of Kalanchoe brasiliensis. , 2002, International immunopharmacology.

[37]  H. Oku,et al.  Cyclooxygenase-2 inhibitory 1,4-naphthoquinones from Impatiens balsamina L. , 2002, Biological & pharmaceutical bulletin.

[38]  S A Rich,et al.  The coxibs, selective inhibitors of cyclooxygenase-2. , 2001, The New England journal of medicine.

[39]  R Day,et al.  Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis. VIGOR Study Group. , 2000, The New England journal of medicine.

[40]  J. Ryu,et al.  Inhibitors of nitric oxide synthesis and TNF-alpha expression from Magnolia obovata in activated macrophages. , 2000, Planta medica.

[41]  Lise,et al.  Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis. VIGOR Study Group. , 2000, The New England journal of medicine.

[42]  R. S. Rogers,et al.  Synthesis and biological evaluation of the 1,5-diarylpyrazole class of cyclooxygenase-2 inhibitors: identification of 4-[5-(4-methylphenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl]benze nesulfonamide (SC-58635, celecoxib). , 1997, Journal of medicinal chemistry.